On-Demand Webinar — Plus, Key Takeaways Document

Rare Diseases

Shaping Biopharma's Future from the Past

A provocative talk on how rare disease development and commercialization has evolved since the days Genzyme pioneered a new path in Gaucher.

Watch this Genzyme-veteran panel for an insightful and provocative discussion on what mistakes to avoid, what to get right early, and how to stand out from the ever-growing pack of competitors in rare disease drug development. 

What essential lessons have we learned, and what questions are we asking ourselves?

  • Will changes in the capital markets hamstring rare disease development?
  • Is the patient still coming first?
  • Has the macro environment changed how we advise companies?
Watch these industry experts address these questions and more.
  • Marnie Hoolahan (Moderator and Managing Director of The NemetzGroup) – Leader, Advisor, and Strategist to biopharma companies from preclinical through commercial 
  • Jim Geraghty – Biopharma Executive, Board Director, and Chair
  • Masako Nakamura – Global Biotech Executive 
  • Paula Soteropoulos – Biotech Executive, Life Sciences Entrepreneur, Board Director, Chairman, Former CEO 
Fill out the form to instantly access this free webinar.
Includes a key takeaways document!

We use cookies to improve user experience and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By using this website you consent to store on your device all the technologies described in our Privacy Policy.